Researchers Identified Blood-Brain Barrier Link in PANS

A Columbia University study points to specific inflammatory markers in children with PANS and PANDAS.

Updated on Sept. 22, 2026 in Autism

A close-up of a laboratory microscope lens over a glass specimen slide showing stained brain tissue cells, representing neurological research. — Columbia University Irving Medical Center researchers identified that cytokine IL-17A plays a key role in blood-brain barrier dysfunction for children with PANS and PANDAS. AI Illustration. Upload story photo >

Live Poll

Do you trust that current medical research accurately identifies the physical causes of complex childhood syndromes?

Researchers at Columbia University Irving Medical Center identified inflammatory processes that disrupt the blood-brain barrier in children with PANS and PANDAS. Published on August 11, 2026, the study provides potential new markers for tracking the progression of these immune-mediated disorders.

Why it matters

Understanding the immune-mediated origins of these neurological symptoms is essential for developing precise diagnostic tools. This research helps clarify why certain infections lead to acute psychiatric and physical symptoms in affected children.

In a study published in Nature Communications, researchers used single-cell RNA sequencing and mouse genetic models to confirm that Group A Streptococcus triggers inflammatory gene changes. The team identified consistent inflammatory cytokines in 23 children compared to control subjects.

The players

Columbia University Irving Medical Center

A prominent research institution where the team conducted the study on neuro-inflammatory disorders.

The details

The study reveals that the cytokine IL-17A plays a critical role in blood-brain barrier dysfunction during PANS and PANDAS. By utilizing mouse genetic studies and computational analysis, researchers demonstrated how this cytokine promotes inflammatory changes in brain microglia and endothelial cells. The team specifically isolated the impact of IL-17A by removing inflammatory cytokines usually produced by T lymphocytes to confirm the pathway responsible for pathology.

2016: Dr. Agalliu identified GAS-induced T lymphocyte migration.
2020: Researchers demonstrated Th17 lymphocytes trigger brain pathology.
August 11, 2026: The research paper was published in Nature Communications.
September 22, 2026: The study findings were publicly announced.

Health Landscape

This work builds on a 15-year effort to understand the immune-mediated roots of PANS and PANDAS. It marks a shift toward identifying the specific molecular drivers of blood-brain barrier disruption that differentiate these disorders from typical post-infectious responses.

If you are caring for a child with suspected PANS or PANDAS, these findings highlight the value of tracking symptom patterns alongside infectious episodes. Discuss the implications of immune-mediated diagnostics with your child's pediatrician or neurologist to understand current testing options.

The takeaway

The study suggests that inflammatory cytokines are central to the blood-brain barrier issues seen in PANS and PANDAS. Families should maintain detailed records of infectious symptoms to discuss with specialists as research into these markers continues.